Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries (Endoc-TC)
Primary Purpose
Moderate to Severe Traumatic Brain Injury
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Biological and behavioral explorations
Sponsored by
About this trial
This is an interventional prevention trial for Moderate to Severe Traumatic Brain Injury focused on measuring Traumatic brain injury, Paediatrics, Hypopituitarism
Eligibility Criteria
Inclusion Criteria:
- children from 2 months to 16 years
- in the intensive care unit
- TBI : moderate (Glasgow Coma Scale (GCS) between 9 and 12) to severe (GCS <9), whatever the mechanism involved
- informed consent form signed by parents
Exclusion Criteria:
- obesity (Body Mass Index (BMI) > 97th percentile for the age)
- patient already under replacement therapy.
- patient taking AntiEpileptic Drugs (AEDs)
- patient with long-term systemic corticotherapy
- history of neurological disease or learning difficulties
- no covered by a national health insurance
Sites / Locations
- CHU de Grenoble
- Hospices Civils de Lyon
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Moderate to severe Traumatic Brain Injury
Arm Description
Assessment of hypopituitarism. Blood tests at different moments: day 0 when leaving intensive care unit month 3 month 12
Outcomes
Primary Outcome Measures
Study the link between pituitary deficiencies highlighted at the acute phase and one year after moderate to severe TBI.
Secondary Outcome Measures
Study the association between pituitary deficiencies highlighted at the acute phase, 3 months and 1 year after moderate to severe TBI, globally and per deficiency category.
Identify the other risk factors of deficiency, during the acute phase and the tardive phase i.e. signs of gravity of the TBI, type of cerebral lesion, age, lesional mechanism.
Study the correlation between corticotropic deficiencies and post-hypophysis insufficiencies during the acute phase and the hemodynamic instability over the first 3 days after the TBI
Compare the level and the type of behavioural and neuropsychological sequelae in children suffering from a TBI, with and without hypopituitarism.
Full Information
NCT ID
NCT01250132
First Posted
November 25, 2010
Last Updated
August 30, 2019
Sponsor
Hospices Civils de Lyon
1. Study Identification
Unique Protocol Identification Number
NCT01250132
Brief Title
Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries
Acronym
Endoc-TC
Official Title
Are Ante-hypophyseal Dysfunctions in the Acute Phase of Moderate to Severe Traumatic Brain Injury Predictive of Long-term Ante-hypophyseal Sequelae in Children?
Study Type
Interventional
2. Study Status
Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
October 2010 (Actual)
Primary Completion Date
April 13, 2018 (Actual)
Study Completion Date
April 13, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Annual incidence of severe traumatic brain injuries (TBI) varies from 180 to 300 out of 100.000. Mortality or severe sequelae risk is increased 8 fold after a TBI. Studies in adults showed an ante-hypophyseal deficit in 28 to 68 % of patients with a TBI. The most common deficit is Growth Hormone Deficit (GHD); followed by gonadotropic and corticotropic (AdrenoCorticoTropic Hormone (ACTH)) insufficiencies. Thyrotropic deficits (Thyroid-Stimulating Hormone (TSH)) are less frequent. From a pathophysiological point of view, the lesional mechanism responsible for hypopituitarisms would be a damage of hypophyseal vessels or hypothalamic-pituitary vessels. The frequency of pituitary deficits and the potential beneficial effects of replacement therapy on quality of life, tiredness, loss of energy and productivity, justify the systematic detection of the deficits in patients with moderate to severe TBI.
Study hypotheses :
At the present time, the lack of data in children does not give us the opportunity to affirm that one part of the symptoms showed by children with post-TBI neuropsychological sequelae, are linked to pituitary deficiency and that they can be improved with a replacement therapy.
Firstly, it is essential to better understand the natural history of post-TBI pituitary deficiencies, studying the connexion between observed deficiencies in acute and late phase of sequelae.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Moderate to Severe Traumatic Brain Injury
Keywords
Traumatic brain injury, Paediatrics, Hypopituitarism
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
110 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Moderate to severe Traumatic Brain Injury
Arm Type
Other
Arm Description
Assessment of hypopituitarism. Blood tests at different moments:
day 0
when leaving intensive care unit
month 3
month 12
Intervention Type
Other
Intervention Name(s)
Biological and behavioral explorations
Intervention Description
Blood dosages:
biochemistry
pituitary gland
somatotropic axis
corticotropic axis
gonadotropic axis
thyrotropic axis
antidiuretic axis
Questionnaires and scales (quality of life, Vineland Adaptive Behavior Scales (VABS)-II)
Primary Outcome Measure Information:
Title
Study the link between pituitary deficiencies highlighted at the acute phase and one year after moderate to severe TBI.
Time Frame
12 months after inclusion
Secondary Outcome Measure Information:
Title
Study the association between pituitary deficiencies highlighted at the acute phase, 3 months and 1 year after moderate to severe TBI, globally and per deficiency category.
Time Frame
day0, when leaving intensive care unit, month3 and month12
Title
Identify the other risk factors of deficiency, during the acute phase and the tardive phase i.e. signs of gravity of the TBI, type of cerebral lesion, age, lesional mechanism.
Time Frame
day0, when leaving intensive care unit, month3 and month12
Title
Study the correlation between corticotropic deficiencies and post-hypophysis insufficiencies during the acute phase and the hemodynamic instability over the first 3 days after the TBI
Time Frame
day0 to day3
Title
Compare the level and the type of behavioural and neuropsychological sequelae in children suffering from a TBI, with and without hypopituitarism.
Time Frame
day0, when leaving intensive care unit, month3 and month12
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Months
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
children from 2 months to 16 years
in the intensive care unit
TBI : moderate (Glasgow Coma Scale (GCS) between 9 and 12) to severe (GCS <9), whatever the mechanism involved
informed consent form signed by parents
Exclusion Criteria:
obesity (Body Mass Index (BMI) > 97th percentile for the age)
patient already under replacement therapy.
patient taking AntiEpileptic Drugs (AEDs)
patient with long-term systemic corticotherapy
history of neurological disease or learning difficulties
no covered by a national health insurance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Etienne JAVOUHEY, MD, PhD
Organizational Affiliation
Hospices Civils de Lyon
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Grenoble
City
Grenoble
ZIP/Postal Code
38 000
Country
France
Facility Name
Hospices Civils de Lyon
City
Lyon
ZIP/Postal Code
69000
Country
France
12. IPD Sharing Statement
Learn more about this trial
Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries
We'll reach out to this number within 24 hrs